March 10 (Reuters) - Radius Health Inc:
* Radius Health Receives notification of PDUFA extension for abaloparatide-sc
* Radius Health Inc- in notice received from FDA last evening, prescription drug user fee act date for abaloparatide-sc has been extended to June 30, 2017
* Radius Health Inc- FDA has not requested any additional information from company
* Radius Health Inc - FDA stated that PDUFA goal date has been extended by three months to allow for a full review of submission Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.